Cargando…

Clinical research and COVID-19: Science is not an option

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academie nationale de medecine 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261098/ https://www.ncbi.nlm.nih.gov/pubmed/32836254 http://dx.doi.org/10.1016/j.banm.2020.05.094

Ejemplares similares

Recherche clinique et COVID-19 : la science n’est pas une option
Publicado: (2020)

The state of social science research on COVID-19
por: Liu, Yan-Li, et al.
Publicado: (2021)

Continued impact of COVID-19 pandemic on clinical and translational science early-career researchers
por: Mayowski, Colleen, et al.
Publicado: (2022)

COVID-19: Immunology and treatment options
por: Felsenstein, Susanna, et al.
Publicado: (2020)

Comment on the article: The state of social science research on COVID‑19
por: Lin, Ju-Kuo, et al.
Publicado: (2022)

Potential Therapeutic Options for COVID-19
por: Zheng, Xiaoqin, et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on scientific research in the life sciences
por: Riccaboni, Massimo, et al.
Publicado: (2022)

Clinical Management of COVID-19: A Review of Pharmacological Treatment Options
por: Heustess, Ashli M., et al.
Publicado: (2021)

The epidemiology and therapeutic options for the COVID-19
por: Li, Jingwei, et al.
Publicado: (2020)

Hemodynamic Monitoring Options in COVID-19
por: Rozental, Olga, et al.
Publicado: (2020)

Medical treatment options for COVID-19
por: Delang, Leen, et al.
Publicado: (2020)

A bibliometric study of COVID-19 research in Web of Science
por: Su, Meiming, et al.
Publicado: (2021)

Treatment options for COVID-19: The reality and challenges
por: Jean, Shio-Shin, et al.
Publicado: (2020)

Research Refines Alcoholism Treatment Options
Publicado: (2000)

Science and Society: Some “Made-in-Canada” Options for Improving Integration
por: Kosseim, Patricia, et al.
Publicado: (2011)

A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy
por: Goswami, Julie, et al.
Publicado: (2021)

Editorial: COVID-19-Social Science Research During a Pandemic
por: Ward, Paul R., et al.
Publicado: (2022)

Science in the time of COVID-19: Reflections on the UK Events Research Programme
por: Marteau, Theresa M., et al.
Publicado: (2022)

COVID-19 Clinical Research
por: Chi, Jeffrey, et al.
Publicado: (2020)

Treatment Options for COVID-19: A Review
por: Ali, Mukarram Jamat, et al.
Publicado: (2020)

COVID-19 Therapeutic Options Under Investigation
por: Kaddoura, Malak, et al.
Publicado: (2020)

Therapeutic Options for COVID-19: A Review
por: Pujari, Rishita, et al.
Publicado: (2020)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

COVID-19 Outbreak: an Update on Therapeutic Options
por: Panati, Kalpana, et al.
Publicado: (2020)

COVID-19 and Possible Pharmacological Preventive Options
por: Duner, Pontus, et al.
Publicado: (2020)

Oncology-Inspired Treatment Options for COVID-19
por: Pillarsetty, Nagavarakishore, et al.
Publicado: (2020)

Stem cells as an option for the treatment of COVID-19
por: Cuevas-González, Maria Veronica, et al.
Publicado: (2022)

Dilemmas and options for COVID-19 vaccination in children
por: Wen, Jingzhi, et al.
Publicado: (2023)

Response to Dr. Chou’s comment on “the state of social science research on COVID-19”
por: Liu, Yan-Li, et al.
Publicado: (2022)

The emerging COVID-19 research: dynamic and regularly updated science maps and analyses
por: Andersen, Njål, et al.
Publicado: (2020)

Impact of COVID-19 on materials science research innovation and related pandemic response
por: Chu, Crystal, et al.
Publicado: (2021)

The immunology of COVID-19: is immune modulation an option for treatment?
por: Zhong, Jixin, et al.
Publicado: (2020)

Remdesivir as a possible therapeutic option for the COVID-19
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2020)

The price of COVID-19-induced uncertainty in the options market()
por: Li, Jianhui, et al.
Publicado: (2022)

The COVID-19 risk in the cross-section of equity options
por: Jitsawatpaiboon, Kanokrak, et al.
Publicado: (2023)

OECD Global Science Forum : Large Research Infrastructures : Report on Roadmapping of Large Research Infrastructures (2008) & Report on Establishing Large International Research Infrastructures : issue and options
por: Collective
Publicado: (2010)

ESPO and Health Sciences Section Symposium: Conducting Clinical Trial Research During the COVID-19 Pandemic: Transforming Research Practice for the Future
por: Morgan, Brianna, et al.
Publicado: (2021)

Revisiting early-stage COVID-19 strategy options
por: Machanick, Philip
Publicado: (2021)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
por: Abubakar, Abdullahi Rabiu, et al.
Publicado: (2020)

COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
por: Bhavana, Valamla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jjae2vp84gpvbldqac528bjnbj